Publications 2011 - 2012

2011

Majid, A., Thet, T. L., Best, G., Fishlock, K., Hewamana, S., Pratt, G., Pepper, C. et al (2011). CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL. LEUKEMIA RESEARCH, 35(6), 750-756. doi:10.1016/j.leukres.2010.10.022

Stadler, L. K. J., Hoffmann, T., Tomlinson, D. C., Song, Q., Lee, T., Busby, M., Ferrigno, P. K. et al (2011). Structure function studies of an engineered scaffold protein derived from Stefin A. II: Development and applications of the SQT variant. PROTEIN ENGINEERING DESIGN & SELECTION, 24(9), 751-763. doi:10.1093/protein/gzr019

Majid, A., Richards, T., Dusanjh, P., Kennedy, D. B. J., Miall, F., Gesk, S., Dyer, M. J. S. et al (2011). TP53 codon 72 polymorphism in patients with chronic lymphocytic leukaemia: identification of a subgroup with mutated IGHV genes and poor clinical outcome. BRITISH JOURNAL OF HAEMATOLOGY, 153(4), 533-535. doi:10.1111/j.1365-2141.2010.08484.x

Willimott, S., Merriam, T., & Wagner, S. D. (2011). Apoptosis induces Bcl-XS and cleaved Bcl-XL in chronic lymphocytic leukaemia.. Biochem Biophys Res Commun, 405(3), 480-485. doi:10.1016/j.bbrc.2011.01.057

Wagner, S. D., Ahearne, M., & Ko Ferrigno, P. (2011). The role of BCL6 in lymphomas and routes to therapy.. Br J Haematol, 152(1), 3-12. doi:10.1111/j.1365-2141.2010.08420.x

2012

Pero, R., Palmieri, D., Angrisano, T., Valentino, T., Federico, A., Keller, S., Wagner, S. D. (2012). POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation. Journal of Biological Chemistry, 287(22), 18308-18317. doi:10.1074/jbc.M112.346270

Willimott, S., & Wagner, S. D. (2012). Stromal cells and CD40 ligand (CD154) alter the miRNome and induce miRNA clusters including, miR-125b/miR-99a/let-7c and miR-17-92 in chronic lymphocytic leukaemia. Leukemia, 26(5), 1113-1116. doi:10.1038/leu.2011.299

Willimott, S., & Wagner, S. D. (2012). miR-125b and miR-155 contribute to BCL2 repression and proliferation in response to CD40 ligand (CD154) in human leukemic B-cells. Journal of Biological Chemistry, 287(4), 2608-2617. doi:10.1074/jbc.M111.285718

Pepper, C., Majid, A., Lin, T. T., Hewamana, S., Pratt, G., Walewska, R.,  Fegan, C. et al (2012). Defining the prognosis of early stage chronic lymphocytic leukaemia patients.. Br J Haematol, 156(4), 499-507. doi:10.1111/j.1365-2141.2011.08974.x

Willimott, S., & Wagner, S. D. (2012). Stromal cells and CD40 ligand (CD154) alter the miRNome and induce miRNA clusters including, miR-125b/miR-99a/let-7c and miR-17-92 in chronic lymphocytic leukaemia.. Leukemia, 26(5), 1113-1116. doi:10.1038/leu.2011.299

 

Share this page:

NEWS

Congratulations from the LCRC to Bethan Rogoyski and Aleksandra Bzura.

Bethan won best oral presentation at the AMS Midlands Academy of Medical Sciences Festival held on 27th March 2019 for her presentation on "Redeployment: The potential of repurposed drugs in preventing mesothelioma".

Aleks won the University PGR poster fair competition on 18th March 2019 for her poster entitled "New hope for treating mesothelioma cancer using PARP inhibitors".

Also, a huge well done to Grandezza Aburido who was in the semi-finals of the PGR poster fair.  

---------------------------------

Congratulations to Noura Alibrahim who passed her PhD viva recently.  Well done!

---------------------------------

In a recent exercise undertaken by the NCRI’s Clinical and Translational Radiotherapy Research Working Group (CTRad) Leicester was rated as internationally competitive/leading in the Radiation Biology Research domain, one of just four centres in the UK to achieve this rating in that domain.

---------------------------------

New: Wellcome Trust Institutional Strategic Support Fund

Details

---------------------------------

Centre Health and Wellbeing Group
Join up for a walk on the park Friday lunchtime - details here.

More information from Jenny McNair jm65@le.ac.uk

Contact Details

Leicester Cancer Research Centre
Clinical Sciences Building
University of Leicester
Leicester Royal Infirmary
Leicester LE2 7LX

T: +44 (0) 116 252 3170
E: cancerstudies@le.ac.uk

(Please note this email address should not be used for clinical referrals or patient correspondence)

Maps and Directions

Sat Nav users: 
LE1 5WW

Accessibility

DisabledGo logo

The University of Leicester is committed to equal access to our facilities. DisabledGo has a detailed accessibility guide for the Robert Kilpatrick Clinical Sciences Building.

Seminars

.